Emergent BioSolutions (EBS) Interest Coverage Ratio (2011 - 2026)

Emergent BioSolutions' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 0.8 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 73.18% year-over-year to 0.8 in Q1 2026; TTM through Mar 2026 was 0.97, a 162.35% increase from a year earlier, with the FY2025 full-year figure at 0.3, up 194.71% from the prior year.
• Interest Coverage Ratio grew to 0.8 in Q1 2026 per EBS's latest filing, from 1.59 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 7.77 in Q3 2024 and bottomed at 12.29 in Q3 2023.
• The 5-year median for Interest Coverage Ratio is 1.59 (2025), against an average of 2.52.
• Across the five-year window, Interest Coverage Ratio slumped 1284.87% in 2022 and surged 163.23% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 4.32 in 2022, then jumped by 53.28% to 2.02 in 2023, then soared by 68.2% to 0.64 in 2024, then slumped by 146.96% to 1.59 in 2025, then surged by 150.56% to 0.8 in 2026.
• Per Business Quant, the three latest EBS Interest Coverage Ratio figures stand at 0.8 (Q1 2026), 1.59 (Q4 2025), and 5.03 (Q3 2025).